Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)
ClinicalTrials.gov study NCT06349512. IPD Sharing: YES. Countries: 1. Publications: 0.
Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04745975. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes
ClinicalTrials.gov study NCT01910844. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06291064. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
ClinicalTrials.gov study NCT05973864. IPD Sharing: NO. Countries: 1. Publications: 0.
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05455658. IPD Sharing: NO. Countries: 1. Publications: 0.
Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03586297. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Preoperative Accelerated Partial Breast Irradiation for Triple Negative Breast Cancer Using Proton Beam Scanning
ClinicalTrials.gov study NCT03340402. IPD Sharing: NO. Countries: 1. Publications: 0.
Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT00472693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast Cancer
ClinicalTrials.gov study NCT07143097. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
ClinicalTrials.gov study NCT01173497. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CMP-001 and Pre-operative Stereotactic Body Radiation Therapy (SBRT) in Early Stage Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT04807192. IPD Sharing: NO. Countries: 1. Publications: 0.
Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer
ClinicalTrials.gov study NCT04193059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform
ClinicalTrials.gov study NCT05916755. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT02531932. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer
ClinicalTrials.gov study NCT03775928. IPD Sharing: NO. Countries: 1. Publications: 0.
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast C
ClinicalTrials.gov study NCT00031681. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06879704. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06492005. IPD Sharing: NO. Countries: 1. Publications: 0.
Triple Negative Breast Cancer Biomarker Study
ClinicalTrials.gov study NCT01111175. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.